TABLE 2.
Occurrence of adverse reactions.
| Adverse reactions | Incidence rate (n, %) | |
|---|---|---|
| Experimental | Control | |
| Dry mouth | 5 (0.89) | 5 (0.90) |
| Nausea | 11 (1.95) | 8 (1.44) |
| Diarrhea | 7 (1.24) | 7 (1.26) |
| Dizziness | 2 (0.36) | 1 (0.18) |
| Skin itching | 3 (0.53) | 0 |
| Increased heart rate | 1 (0.18) | 1 (0.18) |
| Edema | 2 (0.36) | 4 (0.72) |
| Rash | 3 (0.53) | 8 (1.44) |
| Palpitations | 2 (0.36) | 0 |
| Chest tightness | 1 (0.18) | 0 |
| Constipation | 1 (0.18) | 2 (0.36) |
| Indigestion | 1 (0.18) | 1 (0.18) |
| Headache | 3 (0.53) | 5 (0.90) |
| Thrombophlebitis | 1 (0.18) | 2 (0.36) |
| Liver and kidney injury | 1 (0.18) | 1 (0.18) |
| Muscle spasm | 1 (0.18) | 1 (0.18) |
| Gastrointestinal reactions | 3 (0.53) | 1 (0.18) |
| Dyspnea | 1 (0.18) | 2 (0.36) |
| Gastric distension and nausea | 0 | 1 (0.18) |
| Vomiting | 0 | 1 (0.18) |
| Elevated alanine aminotransferase | 1 (0.18) | 0 |